These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29552568)

  • 1. Response of Bortezomib Chemotherapy in Hepatic Amyloidosis.
    Hasan SM; Ahmed NN; Ahmed Z; Seibert A
    J Investig Med High Impact Case Rep; 2018; 6():2324709618760079. PubMed ID: 29552568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Involvement as the Sole Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis: A Diagnostic Challenge.
    Kottavadakkeel N; Rajaram A
    Cureus; 2023 Oct; 15(10):e47310. PubMed ID: 38022076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hepatic amyloidosis: A case report and review of literature.
    Sonthalia N; Jain S; Pawar S; Zanwar V; Surude R; Rathi PM
    World J Hepatol; 2016 Feb; 8(6):340-4. PubMed ID: 26962400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.
    Park MA; Mueller PS; Kyle RA; Larson DR; Plevak MF; Gertz MA
    Medicine (Baltimore); 2003 Sep; 82(5):291-8. PubMed ID: 14530778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases.
    Yim B; Kertowidjojo E; Zhang Y; Patel P
    Case Rep Oncol Med; 2016; 2016():7625940. PubMed ID: 27774327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic amyloidosis: a prevalence study and clinical characterization of a rare and severe disease.
    Dias E; Cardoso H; Marques M; Liberal R; Lopes S; Pereira P; Santos-Antunes J; Pinheiro J; Lopes J; Carneiro F; Macedo G
    Rev Esp Enferm Dig; 2023 Jan; 115(1):16-21. PubMed ID: 35297258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rare Presentation of Multiple Myeloma: A Case Report of Hepatic Amyloidosis.
    Sadeghi A; Nejati M; Moghaddas A
    Iran J Med Sci; 2019 Jul; 44(4):342-346. PubMed ID: 31439978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic amyloidosis--two cases report.
    Jeong HJ; Hahn EK; Kim E; Park CI
    J Korean Med Sci; 1988 Dec; 3(4):151-5. PubMed ID: 3267363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hepatic amyloidosis presenting as nodular masses on the background of diffuse infiltration and extreme liver stiffness on MR elastography.
    Srinivasan S; Tan YQ; Teh HS; Lee PJ; Khoo RN
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):437-40. PubMed ID: 25532004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic amyloidosis as a rare differential diagnosis of progressive liver failure].
    Bettinger D; Lutz L; Schultheiß M; Werner M; Thimme R; Neumann-Haefelin C
    Dtsch Med Wochenschr; 2016 Sep; 141(19):1387-9. PubMed ID: 27642740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Massive hepatic amyloidosis: a case of hepatic failure and haemorrhagic pancreatitis of fatal evolution].
    Jiménez Sáenz M; Martín Guerrero J; Rebollo J; Piñar AL; González Campora R; Herrerías Gutierréz JM
    An Med Interna; 1998 Jun; 15(6):316-8. PubMed ID: 9656512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report.
    Ghazanfar H; Khaja M; Haider A; Yapor L; Kandhi S; Sulh M
    Cureus; 2022 Jul; 14(7):e27274. PubMed ID: 36039232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without obvious liver involvement: unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?].
    Paudice N; Farsetti S; Caroti L; Bandini S; Ciuti G; Tempestini A; Perfetto F; Galli S; Giabbani L; Caldini AL; Bergesio F
    G Ital Nefrol; 2012; 29(1):92-7. PubMed ID: 22388910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary systemic amyloidosis with giant hepatomegaly and portal hypertension: a case report and a review of the literature.
    Serra L; Poppi MC; Criscuolo M; Zandomeneghi R
    Ital J Gastroenterol; 1993 Oct; 25(8):435-8. PubMed ID: 8286779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?
    Takao S; Tanaka K; Miyazaki M; Tanaka M; Ohashi T; Kato M; Kotoh K; Aishima S; Takayanagi R
    Clin J Gastroenterol; 2013 Oct; 6(5):386-9. PubMed ID: 26181836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal manifestations of amyloidosis.
    Ebert EC; Nagar M
    Am J Gastroenterol; 2008 Mar; 103(3):776-87. PubMed ID: 18076735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatic failure due to secondary amyloidosis.
    Köklü S; Odemiş B; Cengiz C; Yüksel O; Usküdar O; Turhan N
    Dig Liver Dis; 2006 Mar; 38(3):208-10. PubMed ID: 16461024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic rupture in systemic amyloidosis - case presentation and review of the literature.
    Skok P; Knehtl M; Ceranić D; Glumbić I
    Z Gastroenterol; 2009 Mar; 47(3):292-5. PubMed ID: 19280544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.